54 DAFTAR PUSTAKA 1. Cotran RS, Kumar V, Collins T. Pathology

DAFTAR PUSTAKA
1. Cotran RS, Kumar V, Collins T. Pathology basic of disease. 6th ed. Philadelphia:
WB Saunders Co,1999.p. 21-20.
2.
Constantinnides P. General pathobiology. 1st ed. Connecticut: Appleton and
Lange,1994.p.173-81.
3. Mast AB. Normal wound healing. In : Achauer B M, Eriksson E . eds. Plastic
surgery, indications, operations and outcomes. St Louis: Mosby, 2000.p. 37-53.
4. Pedersen D. Accelerated surgical stay programe. Annals of surgery 1994 ; 219 :
374 – 81.
5. Bardram L, Funch-Jensen P, Crawford ME, Kehlet H. Recovery after laparoscopic
colonic surgery with epidural analgesia and early oral nutrition and mobilisation.
Lancet 1995 ; 345 : 763-4.
6. Webster EL, Torpy DJ, Elenkov IJ, Chrousos GP. Corticotropin releasing hormone
and inflammation. Annals of the New York Academy of Sciences 1998 ; 840 :
21-32.
7. Carpenter G, Cohen S. Epidermal growth factor. J Biol Chem 1990;265:7709.
8. Angiogenesis and stromal markers in experimental and laryngeal tumor
development.[editorial]
.2002.
Available
from
:
URL
:
http://herkules.oulu.fi/isbn9514269497/html/i251889.html
9. Stoelting RK ed. Local anesthetics. In : Pharmacology and physiology in
anesthetic practice. 3rd ed. Philadelphia: JB Lippincott ,1999.p. 45-67.
54
10. Doctor’s guide : Chirocaine anesthetic use to post op pain management.
[Editorial]
Global
edition.2000.
Available
from
:
URL
:
http://www.pslgroup.com/dg/195B36.htm
11. Pettersson N, Berggren P, Larsson M, Jeff R, Thomsen J. Pain relief by wound
infiltration with bupivacaine or high dose ropivacaine after inguinal hernia repair.
Reg Anesth Pain Med 1999 ; 24 : 569-75.
12. Bultmann M, Streich R, Risse A, Kohn T. Postoperative analgesia in children
after hernioplasty, wound
infiltration
with different
concentrations of
bupivacaine. Anaesthesist 1999 ; 48 : 439-43.
13. Galindo MA. Levobupivacaine, a long acting local anaesthetic, with less cardiac
and
neurotoxicity.2004.
Available
from
:
URL:
http://www.ndaa.ox.ac.uk/wfsa/html/u14/u1407- 01.html
14. Tanra AH. Konsep baru pengelolaan nyeri. Kumpulan makalah PIB X Ikatan
Dokter Spesialis Anestesiologi Indonesia;26-28 Mei 2000;Bandung, Indonesia.
15. Christie JM, Chen GW. Secondary
hyperalgesia is not affected by wound
infiltration with bupivacaine. Can J of An 1993 ; 40 : 1034-7.
16. Vintar N, Pozlep G, Rawal N, Godee N, Rakovec S. Incisional self-administration
of bupivacaine or ropivacaine provides effective analgesia after inguinal hernia
repair. Can J of An 2002 ; 49: 481-6.
17.Wound
healing
[editorial].2000.
Available
from:
http://www.orthoteers.co.uk/Nrujp-ij33lm/orthwound.htm
55
18. Devor M. Pain mechanism and pain syndrome. In : Champbell JN ed. Pain.An
update review. Seattle : IASP press, 1996.p. 103-12.
19. Raymond RG, William GB. Pain management. In : Morgans GE, Mikhail MS.
eds. Clinical anesthesiology. 3th ed. New Jersey: Prentice hall int. Inc,2002.p.
269-73.
20. Kresno BS. Imunologi, diagnosis dan prosedur laboratorium. 4th ed. Jakarta: Balai
penerbit FK UI, 2003.p. 4-32.
21. Pleuvry BJ. The chemical modulation of nociceptive responses and pain.
In :
Healy TEJ, Cohen PJ. eds. A practice of anesthesia. 6th ed. London: Edward
Arnold, 1995.p. 80-8.
22. Roseberg L ,Torre J, Paletta C, Talavera F, Stadelmann W, Slenkovich N, et al.
Wound healing, growth factors.2003 May 12. Available from : URL :
http://www.emedicine.com/plastic/topic457.htm
23. Folkman J, Shing Y. Angiogenesis. J Biol Chem 1992; 267 : 10931-4.
24. Brem S. Angiogenesis and cancer control : From concept to the therapeutic trial.
Cancer Control J 1999;6(5): 980-3.
56
25. Werner S, Grose R. Regulation of wound healing by growth factors and
cytokines. Physiol Rev 2003 ; 83: 835-870.
26. Everson PAG. Histochemistry theoretical and applied. Edinburgh, New
York : Churchill livingstone ,1995.p. 643, 662-3.
27. Edwards W, Hahn CEW, Adams AP. Principle and practice series patients
controlled analgesia. London : BMJ Publ group, 1995 : 1-11.
28. Wasito R. Imunohistokimia. Dalam : Pedoman kuliah imunohistopatologi Dep
Dikbud.
Proyek
pengembangan
pusat
fasilitas
bersama
antar
universitas.Yogyakarta: PAU Bioteknologi – Universitas Gadjah mada, 1991.hal.
36-80.
29. World Health Organization. Research guidelines for evaluating the safety and
efficacy of herbal medicines. New York: WHO Publications, 1993.p.37-41.
30. Sastroasmoro S, Ismael S, Sofyan I. Dasar dasar metodologi penelitian klinis. 2 nd
ed. Jakarta: Sagung seto, 2002.hal.247-399.
31. Samarut J. Nuclear hormone receptors and cytokine membrane receptors in the
control of chicken hematopoietic differentiation and leukemogenesis.2004.
Available from : URL : http://www.scilet.com/bioandbiosafety/pab/pababs4.htm
57
LAMPIRAN GAMBAR
Gambar L.1 Pulasan AgNOR pada kelompok 1 (Tikus yang tidak mendapat perlakuan),
objektif 100X dengan minyak emersi.
Gambar L.2 Pulasan AgNOR pada kelompok 2 (Tikus yang diinfiltrasi tanpa
levobupivakain), objektif 100X dengan minyak emersi.
Gambar L.3 Pulasan AgNOR pada kelompok 3 (Tikus yang diinfiltrasi dengan
levobupivakain), objektif 100X dengan minyak emersi.
Gambar L.4 Gambar mikroskopis c-erbB-2 pada kelompok 1 (Tikus yang tidak
mendapat perlakuan), objektif 100X dengan minyak emersi.
Gambar L.5 Gambar mikroskopis c-erbB-2 pada kelompok 2 (Tikus yang diinfiltrasi
tanpa levobupivakain), objektif 100X dengan minyak emersi.
Gambar L.6 Gambar mikroskopis c-erbB-2 pada kelompok 3 (Tikus yang diinfiltrasi
dengan levobupivakain), objektif 100X dengan minyak emersi.